Researchers Develop Human Marrow-on-a-Chip to Study Immune System and Treat Diseases

Science & Technology News

Researchers Develop Human Marrow-on-a-Chip to Study Immune System and Treat Diseases
BONE MARROWHEMATOPOIESISIMMUNE SYSTEM
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 58 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 71%

Scientists at the University of Pennsylvania, Perelman School of Medicine, and Children's Hospital of Philadelphia have created a groundbreaking 'bone marrow-on-a-chip' that mimics the natural environment of human bone marrow. This innovative platform allows researchers to study the complexities of blood cell production, disease effects, and potential treatments in a controlled and human-relevant setting.

University of Pennsylvania School of Engineering and Applied ScienceJan 31 2025 Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells. This vital function is often disrupted in cancer patients undergoing chemotherapy or radiation, which can damage the marrow and lead to dangerously low white cell counts, leaving patients vulnerable to infection.

The bone marrow-on-a-chip allows researchers to simulate and study common side effects of medical treatments, such as radiotherapy and chemotherapy for cancer patients. When connected to another device, it can even model how the bone marrow communicates with other organs, like the lungs, to protect them from infections and other potentially life-threatening conditions.

Unfortunately, the researchers never had the chance to conduct paired experiments - some on earth, and others on the ISS - whose results they could compare. "Much to our disappointment, the flow controller of the cubelab system required to sustain our engineered tissue models short-circuited during ascent," recalls Huh. "And the second launch was canceled due to the pandemic."

In the past, researchers tried combining these ingredients, but struggled to replicate the structure and behavior of actual human marrow. "All organs in the human body are complex, but the anatomical inaccessibility and unique biological intricacies of human bone marrow has made it a daunting task to model and study its physiology in vitro," says Huh.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

BONE MARROW HEMATOPOIESIS IMMUNE SYSTEM CANCER TREATMENT ORGAN-ON-A-CHIP

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NUS researchers develop DNA barcoded nanoparticles for targeted cancer therapyNUS researchers develop DNA barcoded nanoparticles for targeted cancer therapyA team of researchers from the National University of Singapore (NUS) has developed a novel method to enhance the precision of cancer treatment using gold nanoparticles tagged with DNA barcodes.
Read more »

Penn researchers develop optimized framework for COVID-19 vaccination distributionPenn researchers develop optimized framework for COVID-19 vaccination distributionEngineering and medical researchers at Penn have developed a groundbreaking framework that can determine the best and most computationally optimized distribution strategy for COVID-19 vaccinations in any given community.
Read more »

Queensland Researchers Develop High-Scopolamine Duboisia Varieties for Global Pharmaceutical IndustryQueensland Researchers Develop High-Scopolamine Duboisia Varieties for Global Pharmaceutical IndustryNew varieties of the native Australian plant Duboisia with higher scopolamine content are being developed by researchers at The University of Queensland, offering potential benefits to the global pharmaceutical industry.
Read more »

Researchers Develop Targeted Bacterial Therapy for Cancer TreatmentResearchers Develop Targeted Bacterial Therapy for Cancer TreatmentScientists at the University of Massachusetts Amherst and Ernest Pharmaceuticals have made significant progress in developing a non-toxic bacterial therapy called BacID. This innovative approach delivers cancer-fighting drugs directly into tumors, potentially offering a safer and more effective treatment for cancers with high mortality rates, such as liver, ovarian, and metastatic breast cancer. Clinical trials are expected to begin in 2027.
Read more »

Yale Researchers Develop Novel Cancer Treatment Targeting Multiple Immune Suppression PathwaysYale Researchers Develop Novel Cancer Treatment Targeting Multiple Immune Suppression PathwaysYale University scientists have made a groundbreaking discovery in cancer treatment by developing a new approach that targets multiple pro-tumor actions simultaneously. This innovative strategy utilizes Cas13, a gene editing molecule, to silence immune suppression genes within the tumor microenvironment, leading to significant tumor growth reduction across various cancer types.
Read more »

Australian Researchers Develop Novel Blood Test for EndometriosisAustralian Researchers Develop Novel Blood Test for EndometriosisA breakthrough study published in Human Reproduction reveals a new blood test capable of diagnosing endometriosis, a debilitating condition affecting one in nine Australian women and girls. The non-invasive test identifies 10 protein biomarkers in the blood that can indicate the presence of endometriosis, offering a faster and more accurate diagnosis compared to the current average wait of seven years.
Read more »



Render Time: 2025-02-12 09:58:21